Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Malignant Melanoma

Free Subscription Articles published in Eur J Dermatol Retrieve available abstracts of 73 articles: HTML format

Single Articles

June 2021
1. ARNE V, Canan G, Marjan G
   A narrative review on the outcome of primary cutaneous melanomas arising in solid organ transplant recipients.
   Eur J Dermatol. 2021 Jun 2. pii: ejd.2021.4067. doi: 10.1684/ejd.2021.4067.
   PubMed     Abstract available
   
   
   April 2021
2. BANCALARI B, Ferrer-Guillen S, Tejera-Vaquerizo A, Requena C, et al
   Longitudinal study of prognostic factors for localized cutaneous melanoma in patients who have been disease-free for five years.
   Eur J Dermatol. 2021 Apr 19. pii: ejd.2021.4022. doi: 10.1684/ejd.2021.4022.
   PubMed     Abstract available
   
   
   
3. SCARD C, Nguyen JM, Varey E, Moustaghfir I, et al
   Cardiac adverse events associated with anti-PD-1 therapy in patients treated for advanced melanoma: relevance of dosing troponin T levels.
   Eur J Dermatol. 2021 Apr 2. pii: ejd.2021.4009. doi: 10.1684/ejd.2021.4009.
   PubMed     Abstract available
   
   
   
4. JOVIC A, Tiodorovic D, Popovic D, Vidovic N, et al
   Multiple eruptive squamous cell carcinomas: a possible clinical sign in melanoma patients treated with vemurafenib.
   Eur J Dermatol. 2021;31:279-280.
   PubMed    
   
   
   March 2021
5. MILLAN-ESTEBAN D, Garcia-Casado Z, Manrique-Silva E, Viros A, et al
   Distribution and clinical role of KIT gene mutations in melanoma according to subtype: a study of 492 Spanish patients.
   Eur J Dermatol. 2021 Mar 1. pii: ejd.2021.3971. doi: 10.1684/ejd.2021.3971.
   PubMed     Abstract available
   
   
   February 2021
6. RUSSO I, Filoni A, Alaibac M
   Persistence of superficial basal cell carcinoma during pembrolizumab treatment for metastatic melanoma.
   Eur J Dermatol. 2021 Feb 12. pii: ejd.2020.3958. doi: 10.1684/ejd.2020.3958.
   PubMed    
   
   
   December 2020
7. LUDWIG SV, F Cheng P, Mangana J, Braun R, et al
   Survival and therapeutic response in patients with melanoma of unknown and known primary: a single-centre retrospective analysis.
   Eur J Dermatol. 2020;30:699-709.
   PubMed     Abstract available
   
   
   November 2020
8. MORA-FERNANDEZ V, Boada A, Manzano JL, Jaka A, et al
   Locally advanced head and neck squamous cell carcinoma and melanoma simultaneously treated with pembrolizumab: an unusual situation.
   Eur J Dermatol. 2020 Nov 24. pii: ejd.2020.3911. doi: 10.1684/ejd.2020.3911.
   PubMed    
   
   
   October 2020
9. GRAN F, Weber J, Schummer P, Kneitz H, et al
   Sarcoidosis developing upon immune checkpoint inhibition in advanced uveal melanoma.
   Eur J Dermatol. 2020;30:629-631.
   PubMed    
   
   
   September 2020
10. OGATA D, Murakami T, Arai E, Tsuchida T, et al
    A case of malignant melanoma of the areola in a male patient.
    Eur J Dermatol. 2020 Sep 18. pii: ejd.2020.3865. doi: 10.1684/ejd.2020.3865.
    PubMed    
    
    
    August 2020
11. DALLE S, Varey E, Nguyen JM, Dupuy A, et al
    Management of adjuvant settings for Stage III melanoma patients in France prior to checkpoint inhibitors: epidemiological data from the RIC-Mel database.
    Eur J Dermatol. 2020 Aug 19. pii: ejd.2020.3848. doi: 10.1684/ejd.2020.3848.
    PubMed     Abstract available
    
    
    
12. GIAVINA-BIANCHI M, Giavina-Bianchi P, Sotto MN, Rodig S, et al
    Nodular primary cutaneous melanoma is associated with PD-L1 expression.
    Eur J Dermatol. 2020;30:352-357.
    PubMed     Abstract available
    
    
    February 2020
13. GRAN F, Emmerich K, Mohme S, Goebeler M, et al
    Vitiligo-like lesions developing upon immune checkpoint inhibition in advanced melanoma.
    Eur J Dermatol. 2020;30:72-73.
    PubMed    
    
    
    December 2019
14. NIIJIMA Y, Ishitsuka Y, Inoue S, Maruyama H, et al
    Reconstruction using a vertical "sagging cheek" advancement flap for defects following full-thickness excision of non-melanoma skin cancer in the elderly: a case series.
    Eur J Dermatol. 2019;29:654-656.
    PubMed    
    
    
    
15. EL KHOURY R, Michael-Jubeli R, Bakar J, Dakroub H, et al
    Origanum essential oils reduce the level of melanin in B16-F1 melanocytes.
    Eur J Dermatol. 2019;29:596-602.
    PubMed     Abstract available
    
    
    October 2019
16. BASSET SEGUIN N, Malvehy J, Nadal F, Creancier L, et al
    Risk behaviour and patient preferences for an improved non-melanoma skin cancer prevention modality for organ-transplanted patients; a European, multi-country, online patient community study.
    Eur J Dermatol. 2019 Oct 23. pii: ejd.2019.3639. doi: 10.1684/ejd.2019.3639.
    PubMed     Abstract available
    
    
    
17. MOTEGI SI, Sekiguchi A, Toki S, Kishi C, et al
    Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease.
    Eur J Dermatol. 2019 Oct 16. pii: ejd.2019.3634. doi: 10.1684/ejd.2019.3634.
    PubMed     Abstract available
    
    
    June 2019
18. ARIANAYAGAM S, Ieremia E, Matin RN
    Delayed skin toxicity associated with pembrolizumab therapy for metastatic melanoma.
    Eur J Dermatol. 2019;29:349-351.
    PubMed    
    
    
    
19. BOCQUET-TREMOUREUX S, Scharbarg E, Nguyen JM, Varey E, et al
    Efficacy and safety of nivolumab in metastatic melanoma: real-world practice.
    Eur J Dermatol. 2019;29:315-321.
    PubMed     Abstract available
    
    
    April 2019
20. SAMPOGNA F, Paradisi A, Iemboli ML, Ricci F, et al
    Comparison of quality of life between melanoma and non-melanoma skin cancer patients.
    Eur J Dermatol. 2019;29:185-191.
    PubMed     Abstract available
    
    
    
21. ARACTINGI S, Pellacani G
    Computational neural network in melanocytic lesions diagnosis: artificial intelligence to improve diagnosis in dermatology?
    Eur J Dermatol. 2019;29.
    PubMed     Abstract available
    
    
    
22. TAKIMOTO R, Honda T, Kataoka TR, Ueshima C, et al
    DIHS/DRESS-like eruption possibly induced by amoxicillin during treatment with nivolumab.
    Eur J Dermatol. 2019;29:228-229.
    PubMed    
    
    
    February 2019
23. GRAN F, Goebeler M, Gesierich A
    Erythema multiforme-like rash upon anti-melanoma therapy with BRAF and MEK inhibitors.
    Eur J Dermatol. 2019;29:107-108.
    PubMed    
    
    
    December 2018
24. FRINGS VG, Goebeler M, Kneitz H
    Dermpath & Clinic: In situ melanoma arising within a speckled lentiginous nevus.
    Eur J Dermatol. 2018;28:857-859.
    PubMed    
    
    
    
25. GUTZMER R, Harrington KJ, Hoeller C, Lebbe C, et al
    Practical clinical guide on the use of talimogene laherparepvec monotherapy in patients with unresectable melanoma in Europe.
    Eur J Dermatol. 2018;28:736-749.
    PubMed     Abstract available
    
    
    November 2018
26. MINOWA T, Kato J, Hida T, Horimoto K, et al
    Prognostic role of platelet to lymphocyte and lymphocyte to monocyte ratios in advanced melanoma treated with anti-programmed death-1.
    Eur J Dermatol. 2018 Nov 8. pii: ejd.2018.3381. doi: 10.1684/ejd.2018.3381.
    PubMed    
    
    
    October 2018
27. BREGEON B, Nguyen JM, Varey E, Quereux G, et al
    Positive margins after surgical excision of locoregional cutaneous melanoma metastasis and their impact on patient outcome.
    Eur J Dermatol. 2018 Oct 30. pii: ejd.2018.3402. doi: 10.1684/ejd.2018.3402.
    PubMed     Abstract available
    
    
    
28. BEAUDOUX O, Riffaud L, Barbe C, Grange F, et al
    Prognostic factors and incidence of primary mucosal melanoma: a population-based study in France.
    Eur J Dermatol. 2018 Oct 30. pii: ejd.2018.3398. doi: 10.1684/ejd.2018.3398.
    PubMed     Abstract available
    
    
    
29. DE CASTRO ARAUJO BL, Santos Thuler LC, De Melo AC
    Prognostic impact of tumescent local anaesthesia on survival and recurrence of melanoma following lymphadenectomy.
    Eur J Dermatol. 2018 Oct 23. pii: ejd.2018.3414. doi: 10.1684/ejd.2018.3414.
    PubMed    
    
    
    
30. SOARES AM, Szejnfeld VL, Enokihara MY, Michalany N, et al
    High serum 25-hydroxyvitamin D concentration in patients with a recent diagnosis of non-melanoma skin cancer: a case-control study.
    Eur J Dermatol. 2018 Oct 23. pii: ejd.2018.3401. doi: 10.1684/ejd.2018.3401.
    PubMed     Abstract available
    
    
    
31. GAO HW, Tsai WC, Perng CL, Wang WM, et al
    Distinct MAPK and PI3K pathway mutations in different melanoma types in Taiwanese individuals.
    Eur J Dermatol. 2018 Oct 15. pii: ejd.2018.3359. doi: 10.1684/ejd.2018.3359.
    PubMed     Abstract available
    
    
    
32. FANIA L, Abeni D, Esposito I, Spagnoletti G, et al
    Increased incidence of cutaneous melanoma in organ transplant recipients based on a single-centre longitudinal study in Rome, Italy.
    Eur J Dermatol. 2018 Oct 15. pii: ejd.2018.3346. doi: 10.1684/ejd.2018.3346.
    PubMed    
    
    
    
33. NAKAMURA Y, Ishitsuka Y, Fujisawa Y, Konishi R, et al
    Pelvic reactive lymphadenopathy mimicking lymph node metastasis of heel malignant melanoma.
    Eur J Dermatol. 2018 Oct 15. pii: ejd.2018.3416. doi: 10.1684/ejd.2018.3416.
    PubMed    
    
    
    
34. YOKOTA K, Matsumoto T, Urata T, Goto K, et al
    The benefits of high-resolution, real-time colour-imaging of lymphatic flow for sentinel lymph node biopsy.
    Eur J Dermatol. 2018;28:680-681.
    PubMed    
    
    
    August 2018
35. STEMBRIDGE N, Davies A, Chan J, Todd P, et al
    Dermpath and Clinic: A red scaly lesion on the forearm.
    Eur J Dermatol. 2018;28:568-569.
    PubMed    
    
    
    June 2018
36. SAITO A, Fujisawa Y, Maruyama H, Nakamura Y, et al
    Subungual melanoma complicated by hydroxyurea-induced melanonychia with non-melanoma Hutchinson's sign.
    Eur J Dermatol. 2018 Jun 22. pii: ejd.2018.3345. doi: 10.1684/ejd.2018.3345.
    PubMed    
    
    
    
37. KOGAME T, Kaku Y, Endo Y, Yamashita C, et al
    A follow-up report of acral melanoma in a patient with Nagashima-type palmoplantar keratosis: validation of SERPINB7 mutation and local recurrence.
    Eur J Dermatol. 2018 Jun 11. pii: ejd.2018.3317. doi: 10.1684/ejd.2018.3317.
    PubMed    
    
    
    April 2018
38. OISO N, Sakai K, Yanagihara S, Nishio K, et al
    Genital mucosal melanoma with somatic SF3B1 R625C mutation.
    Eur J Dermatol. 2018 Apr 6. pii: ejd.2018.3281. doi: 10.1684/ejd.2018.3281.
    PubMed    
    
    
    
39. SILVA ESD, Tavares R, Paulitsch FDS, Zhang L, et al
    Use of sunscreen and risk of melanoma and non-melanoma skin cancer: a systematic review and meta-analysis.
    Eur J Dermatol. 2018 Apr 5. pii: ejd.2018.3251. doi: 10.1684/ejd.2018.3251.
    PubMed     Abstract available
    
    
    
40. CHAPUT L, Laurent E, Pare A, Sallot A, et al
    One-step surgical removal of cutaneous melanoma with surgical margins based on preoperative ultrasound measurement of the thickness of the melanoma.
    Eur J Dermatol. 2018 Apr 5. pii: ejd.2018.3298. doi: 10.1684/ejd.2018.3298.
    PubMed     Abstract available
    
    
    
41. KOFLER L, Breuninger H, Hafner HM, Schweinzer K, et al
    Lymph node dissection for melanoma using tumescence local anaesthesia: an observational study.
    Eur J Dermatol. 2018 Apr 5. pii: ejd.2018.3250. doi: 10.1684/ejd.2018.3250.
    PubMed     Abstract available
    
    
    
42. ANSELMO LIMA C, Sampaio Lima M, Maria Da Silva A, Prado Nunes MA, et al
    Do cancer registries play a role in determining the incidence of non-melanoma skin cancers?
    Eur J Dermatol. 2018 Apr 5. pii: ejd.2018.3248. doi: 10.1684/ejd.2018.3248.
    PubMed     Abstract available
    
    
    
43. MICANTONIO T, Neri L, Longo C, Grassi S, et al
    A new dermoscopic algorithm for the differential diagnosis of facial lentigo maligna and pigmented actinic keratosis.
    Eur J Dermatol. 2018;28:162-168.
    PubMed     Abstract available
    
    
    February 2018
44. SHOBATAKE C, Miyagawa F, Ogawa K, Azukizawa H, et al
    Preoperative assessment of tumour thickness and vascularity using high-frequency ultrasonography in ten cases of cutaneous melanoma.
    Eur J Dermatol. 2018 Feb 5. pii: ejd.2018.3223. doi: 10.1684/ejd.2018.3223.
    PubMed    
    
    
    
45. TAKIMOTO R, Otsuka A, Kaku Y, Honda T, et al
    No recurrence of nivolumab-induced idiopathic thrombocytopenic purpura in a metastatic melanoma patient switched to ipilimumab.
    Eur J Dermatol. 2018 Feb 5. pii: ejd.2017.3151. doi: 10.1684/ejd.2017.3151.
    PubMed    
    
    
    
46. OYA K, Nakamura Y, Fujisawa Y, Endo R, et al
    Third-line pembrolizumab-induced immune-related interstitial pneumonitis after ipilimumab and nivolumab failure.
    Eur J Dermatol. 2018;28:129-130.
    PubMed    
    
    
    January 2018
47. FINON A, Zaragoza J, Maillard H, Beneton N, et al
    A high neutrophil to lymphocyte ratio prior to BRAF inhibitor treatment is a predictor of poor progression-free survival in patients with metastatic melanoma.
    Eur J Dermatol. 2018 Jan 16. pii: ejd.2017.3167. doi: 10.1684/ejd.2017.3167.
    PubMed     Abstract available
    
    
    November 2017
48. STEFANAKI C, Soura E, Plaka M, Chasapi V, et al
    A case series of paediatric and adolescent melanoma.
    Eur J Dermatol. 2017 Nov 27. pii: ejd.2017.3188. doi: 10.1684/ejd.2017.3188.
    PubMed    
    
    
    
49. COLOMBINO M, Paliogiannis P, Pagliarello C, Cossu A, et al
    Dermoscopy and confocal microscopy for metachronous multiple melanomas: morphological, clinical, and molecular correlations.
    Eur J Dermatol. 2017 Nov 27. pii: ejd.2017.3206. doi: 10.1684/ejd.2017.3206.
    PubMed     Abstract available
    
    
    
50. FUKUMOTO T, Fujiwara S, Sakaguchi M, Oka M, et al
    A case of malignant melanoma that developed multiple metastases after switching from interferon-beta to pegylated interferon-alpha-2b as adjuvant therapy.
    Eur J Dermatol. 2017 Nov 24. pii: ejd.2017.3169. doi: 10.1684/ejd.2017.3169.
    PubMed    
    
    
    
51. RICCI F, Paradisi A, Maier SA, Kovacs M, et al
    Melanoma and tattoos: a case report and review of the literature.
    Eur J Dermatol. 2017 Nov 24. pii: ejd.2017.3184. doi: 10.1684/ejd.2017.3184.
    PubMed     Abstract available
    
    
    
52. CUNHA N, Campos S, Serrao V
    Vitamin D levels in a cohort of Portuguese melanoma patients relate to time of follow-up from diagnosis, sun-exposure behaviour, and use of photoprotection.
    Eur J Dermatol. 2017 Nov 24. pii: ejd.2017.3161. doi: 10.1684/ejd.2017.3161.
    PubMed    
    
    
    
53. OGATA D, Uhara H, Tsutsumida A, Yamazaki N, et al
    Nail apparatus melanoma in a Japanese population: a comparative study of surgical procedures and prognoses in a large series of 151 cases.
    Eur J Dermatol. 2017 Nov 22. doi: 10.1684/ejd.2017.3133.
    PubMed     Abstract available
    
    
    October 2017
54. KOMORI T, Otsuka A, Kusuba N, Taniguchi K, et al
    Rapid regression of metastatic brain tumours in a melanoma patient after dabrafenib/trametinib therapy.
    Eur J Dermatol. 2017;27:548-549.
    PubMed    
    
    
    
55. RUSSO I, Zorzetto L, Frigo AC, Chiarion Sileni V, et al
    A comparative study of the cutaneous side effects between BRAF monotherapy and BRAF/MEK inhibitor combination therapy in patients with advanced melanoma: a single-centre experience.
    Eur J Dermatol. 2017;27:482-486.
    PubMed     Abstract available
    
    
    September 2017
56. BORIK L, Balagula Y, Hinds GA, Loss MJ, et al
    Non-melanoma skin cancers in African American solid organ transplant recipients: regional bias or a real need for surveillance?
    Eur J Dermatol. 2017 Sep 23. doi: 10.1684/ejd.2017.3059.
    PubMed    
    
    
    
57. TEJERA-VAQUERIZO A, Descalzo-Gallego MA, Traves V, Requena C, et al
    The intriguing effect of delay time to sentinel lymph node biopsy on survival: a propensity score matching study on a cohort of melanoma patients.
    Eur J Dermatol. 2017 Sep 23. doi: 10.1684/ejd.2017.3065.
    PubMed     Abstract available
    
    
    May 2017
58. PARADISI A, Didona B, Tabolli S, Ricci F, et al
    Reduced frequency of non-melanoma skin cancer in 72,739 patients with psoriasis: a retrospective study.
    Eur J Dermatol. 2017 May 19. doi: 10.1684/ejd.2017.3032.
    PubMed     Abstract available
    
    
    
59. BASSINO S, Ribero S, Miniotti M, Picardi A, et al
    Emotional distress and health-related quality of life among cutaneous melanoma follow-up outpatients: the role of self-perception of body image and surgical scarring.
    Eur J Dermatol. 2017 May 19. doi: 10.1684/ejd.2017.3048.
    PubMed    
    
    
    
60. DIKA E, Ravaioli GM, Fanti PA, Piraccini BM, et al
    Cutaneous adverse effects during ipilimumab treatment for metastatic melanoma: a prospective study.
    Eur J Dermatol. 2017 May 19. doi: 10.1684/ejd.2017.3023.
    PubMed     Abstract available
    
    
    
61. DIKA E, Fanti PA, Vaccari S, Capizzi E, et al
    Oestrogen and progesterone receptor in melanoma and nevi: an immunohistochemical study.
    Eur J Dermatol. 2017 May 19. doi: 10.1684/ejd.2017.3019.
    PubMed     Abstract available
    
    
    
62. DRAGO F, Ciccarese G, Cogorno L, Calvi C, et al
    Prevention of non-melanoma skin cancers with nicotinamide in transplant recipients: a case-control study.
    Eur J Dermatol. 2017 May 3. doi: 10.1684/ejd.2017.3025.
    PubMed     Abstract available
    
    
    March 2017
63. VILDY S, Nguyen JM, Gaultier A, Knol AC, et al
    Impact of the time interval between lymph node recurrence and lymphadenectomy on melanoma patient survival.
    Eur J Dermatol. 2017 Mar 2. doi: 10.1684/ejd.2016.2955.
    PubMed     Abstract available
    
    
    
64. TSUTSUMI R, Yoshida Y, Yamada N, Adachi K, et al
    Nagashima-type palmoplantar keratosis with melanoma: absence of epidermal Langerhans cells in hyperkeratotic skin.
    Eur J Dermatol. 2017 Mar 1. doi: 10.1684/ejd.2016.2960.
    PubMed    
    
    
    February 2017
65. THIERAUF J, Veit JA, Hess J, Treiber N, et al
    Checkpoint inhibition for advanced mucosal melanoma.
    Eur J Dermatol. 2017 Feb 3. doi: 10.1684/ejd.2016.2949.
    PubMed     Abstract available
    
    
    January 2017
66. ASTRUA C, Fava P, Brizio M, Savoia P, et al
    A study of melanoma in Eastern European migrants in Italy.
    Eur J Dermatol. 2017 Jan 5. doi: 10.1684/ejd.2016.2950.
    PubMed     Abstract available
    
    
    December 2016
67. OISHI K, Nakao M, Maeda S, Matsushita T, et al
    A case of aseptic meningitis without neck rigidity occurring in a metastatic melanoma patient treated with ipilimumab.
    Eur J Dermatol. 2016 Dec 22. doi: 10.1684/ejd.2016.2943.
    PubMed    
    
    
    
68. ISHIKAWA K, Shono-Saito T, Yamate T, Kai Y, et al
    A case of fulminant type 1 diabetes mellitus, with a precipitous decrease in pancreatic volume, induced by nivolumab for malignant melanoma: analysis of HLA and CTLA-4 polymorphisms.
    Eur J Dermatol. 2016.
    PubMed    
    
    
    
69. BETTI R, Moneghini L, Vergani R, Cerri A, et al
    Diagnostic performance parameters for melanocytic lesions before and during the dermoscopy era.
    Eur J Dermatol. 2016.
    PubMed    
    
    
    November 2016
70. FUKUMOTO T, Fujiwara S, Sakaguchi M, Oka M, et al
    Long-term survival of a patient with metastatic melanoma treated with nivolumab and vemurafenib, with the development of vitiligo.
    Eur J Dermatol. 2016.
    PubMed    
    
    
    September 2016
71. FINK L, Amelio J, Harries M, Lebbe C, et al
    Making decisions on resectability and injectability status of lesions in the management of advanced melanoma in Germany, France and the UK.
    Eur J Dermatol. 2016.
    PubMed     Abstract available
    
    
    July 2016
72. KUONEN F, Aschwanden J, Dimaio DJ, Elston DM, et al
    Colonisation of basal cell carcinoma by lentigo maligna: a case report, review of the literature, and series follow-up.
    Eur J Dermatol. 2016.
    PubMed     Abstract available
    
    
    June 2016
73. CINOTTI E, Perrot JL, Labeille B, Biron AC, et al
    Skin tumours and skin aging in 209 French elderly people: the PROOF study.
    Eur J Dermatol. 2016.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: